ENLIVEX THERAP.LTD.IS-,01/ IL0011319527 /
| 9/29/2023 8:00:18 AM | Chg. -0.1000 | Volume | Bid9:58:24 PM | Ask9:58:24 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.4000EUR | -6.67% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 1.4000 | 1.4000 |
GlobeNewswire
3/8/2022
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
GlobeNewswire
2/22/2022
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi,...
GlobeNewswire
1/3/2022
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet N...
GlobeNewswire
12/13/2021
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Seve...
GlobeNewswire
12/7/2021
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
GlobeNewswire
12/6/2021
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Treatment of Sepsis Pa...
GlobeNewswire
11/22/2021
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
GlobeNewswire
11/10/2021
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in...
GlobeNewswire
11/4/2021
Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain
GlobeNewswire
10/12/2021
Enlivex CSO Prof. Dror Mevorach Publishes Foundational Paper on the Pfizer–BioNTech COVID-19 Vaccin...
GlobeNewswire
10/5/2021
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from ...
GlobeNewswire
10/4/2021
Enlivex Announces the Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data from Pha...
GlobeNewswire
9/22/2021
Enlivex Doses First Patient in Placebo-Controlled Phase IIb Clinical Trial Evaluating Allocetra in S...
GlobeNewswire
9/9/2021
Enlivex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
8/15/2021
Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-...
GlobeNewswire
8/9/2021
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
GlobeNewswire
8/2/2021
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cG...
GlobeNewswire
7/21/2021
Enlivex to Present at the Improvate Life-Saving Technologies International Conference 2021
GlobeNewswire
7/12/2021
Enlivex Initiates Design and Construction Process for a New cGMP Allocetra Manufacturing Plant
GlobeNewswire
6/16/2021
Enlivex Annouces Participation in A.G.P.’s Upcoming 2021 Virtual Summer Healthcare Symposium